Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Alexandre Just

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|June 1, 2022
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohortViolaine Gorgeu, Bruno Borghese, Meriem Koual, et al.
Clinical Chemistry|March 24, 2022
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial CarcinomaGuillaume Beinse, Bruno Borghese, Marie Métairie, et al.
Journal of Hepatology|March 12, 2018
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activationShirley Abitbol, Rajae Dahmani, Cédric Coulouarn, et al.
Gynecologic Oncology|September 16, 2022
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupSabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Journal of the National Cancer Institute|December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 TrialCéline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
British Journal of Cancer|June 25, 2022
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancersGuillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, et al.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2020
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217Naoto Kuroda, Kiril Trpkov, Yuan Gao, et al.
Acta Neuropathologica Communications|May 7, 2026
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related featuresMartin Raby, Alexis Trécourt, Euphrasie Servant, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancerMichel Wassef, Armelle Luscan, Setareh Aflaki, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|June 1, 2022
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohortViolaine Gorgeu, Bruno Borghese, Meriem Koual, et al.
Clinical Chemistry|March 24, 2022
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial CarcinomaGuillaume Beinse, Bruno Borghese, Marie Métairie, et al.
Journal of Hepatology|March 12, 2018
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activationShirley Abitbol, Rajae Dahmani, Cédric Coulouarn, et al.
Gynecologic Oncology|September 16, 2022
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupSabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Journal of the National Cancer Institute|December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 TrialCéline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
British Journal of Cancer|June 25, 2022
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancersGuillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, et al.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2020
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217Naoto Kuroda, Kiril Trpkov, Yuan Gao, et al.
Acta Neuropathologica Communications|May 7, 2026
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related featuresMartin Raby, Alexis Trécourt, Euphrasie Servant, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancerMichel Wassef, Armelle Luscan, Setareh Aflaki, et al.
Pageof 8